DDRE-25. NOVEL TEMOZOLOMIDE ANALOGS TO IMPROVE ANTI-TUMOR EFFICACY AND OVERCOME RESISTANCE IN GLIOBLASTOMA MULTIFORME

Glioblastoma (GBM) is considered one of the most lethal forms of human cancers, and despite considerable advances in multimodality treatments, it remains an incurable disease with an overall survival of 14 to 16 months after diagnosis. Even in the era of personalized medicine and immunotherapy, temo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Waters, Ariana, Tomimatsu, Nozomi, Babic, Ivan, Nurmemmedov, Elmar, Allnutt, Annamarie, Quan, Yueqin, Nomura, Natsuko, Burma, Sandeep, Kesari, Santosh, Yenugonda, Venkata
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Drug Discovery, Drug Resistance
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650350/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.270
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi